Abstract
Mycobacterium tuberculosis is the most common communicable infectious disease worldwide and the top killer of human immunodeficiency virus (HIV)-infected people. Because of common dual HIV and M. tuberculosis infections, the emergence of multidrug-resistant M. tuberculosis strains, the lack of effective vaccination, the morbidity, and the mortality of M. tuberculosis infection are increasing sharply. Therefore, there is an urgent need for vaccine and drug development against M. tuberculosis infection. These require appropriate animal models that closely resemble human disease. To this end, we infected Chinese rhesus macaques with the M. tuberculosis H37Rv strain. Bronchoscopy was used to inoculate nine monkeys with different doses of M. tuberculosis H37Rv strain. Regardless of the M. tuberculosis dose, all monkeys were infected successfully. This was shown by clinical, laboratory, and histopathology assessments. Among nine infected monkeys, six developed acute rapid progressive tuberculosis and the remaining animals mirrored early-stage chronic disease. These data, taken together, demonstrate that Chinese rhesus macaques are highly susceptible to M. tuberculosis infection and develop similar manifestations of disease that are seen in humans. This model affords new opportunities for studies of M. tuberculosis disease pathology and therapeutics.
Similar content being viewed by others
Abbreviations
- ABSL:
-
Animal biosafety level
- CRP:
-
C-reactive protein
- CFU:
-
Colony forming units
- ESR:
-
Erythrocyte sedimentation rate
- OT:
-
Old tuberculin
- PI:
-
Post-inoculation
- SIV:
-
Simian immunodeficiency virus
- TST:
-
Tuberculin skin test
- TB:
-
Tuberculosis
- WHO:
-
World Health Organization
References
Capuano SV 3rd, Croix DA, Pawar S, Zinovik A, Myers A, Lin PL, Bissel S, Fuhrman C, Klein E, Flynn JL (2003) Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect Immun 71:5831–5844
Chaparas SD, Good RC, Janicki BW (1975) Tuberculin-induced lymphocyte transformation and skin reactivity in monkeys vaccinated or not vaccinated with Bacille Calmette-Guerin, then challenged with virulent Mycobacterium tuberculosis. Am Rev Respir Dis 112:43–47
Dietrich G, Viret JF, Hess J (2003) Mycobacterium bovis BCG-based vaccines against tuberculosis: novel developments. Vaccine 21:667–670
Good RC (1968) Biology of the mycobacterioses. Simian tuberculosis: immunologic aspects. Ann NY Acad Sci 154:200–213
Gormus BJ, Blanchard JL, Alvarez XH, Didier PJ (2004) Evidence for a rhesus monkey model of asymptomatic tuberculosis. J Med Primatol 33:134–145
Gupta UD, Katoch VM (2005) Animal models of tuberculosis. Tuberculosis (Edinb) 85:277–293
Helke KL, Mankowski JL, Manabe YC (2006) Animal models of cavitation in pulmonary tuberculosis. Tuberculosis (Edinb) 86:337–348
Langermans JA, Andersen P, van Soolingen D, Vervenne RA, Frost PA, van der Laan T, van Pinxteren LA, van den Hombergh J, Kroon S, Peekel I, Florquin S, Thomas AW (2001) Divergent effect of Bacillus Calmette-Guerin (BCG) vaccination on Mycobacterium tuberculosis infection in highly related macaque species: implications for primate models in tuberculosis vaccine research. Proc Natl Acad Sci USA 98:11497–11502
Lin PL, Pawar S, Myers A, Pegu A, Fuhrman C, Reinhart TA, Capuano SV, Klein E, Flynn JL (2006) Early events in Mycobacterium tuberculosis infection in cynomolgus macaques. Infect Immun 74:3790–3803
Ribi E, Anacker RL, Barclay WR, Brehmer W, Harris SC, Leif WR, Simmons J (1971) Efficacy of mycobacterial cell walls as a vaccine against airborne tuberculosis in the rhesus monkey. J Infect Dis 123:527–538
Sugawara I, Li Z, Sun L, Udagawa T, Taniyama T (2007) Recombinant BCG Tokyo (Ag85A) protects cynomolgus monkeys (Macaca fascicularis) infected with H37Rv Mycobacterium tuberculosis. Tuberculosis (Edinb) 87:518–525
Sugawara I, Sun L, Mizuno S, Taniyama T (2009) Protective efficacy of recombinant BCG Tokyo (Ag85A) in rhesus monkeys (Macaca mulatta) infected intratracheally with H37Rv Mycobacterium tuberculosis. Tuberculosis (Edinb) 89:62–67
Trichel AM, Rajakumar PA, Murphey-Corb M (2002) Species-specific variation in SIV disease progression between Chinese and Indian subspecies of rhesus macaque. J Med Primatol 31:171–178
UNAIDS (2010). The Joint United Nations Programme on HIV/AIDS. HIV and tuberculosis: ensuring universal access and protection of human rights. http://data.unaids.org/pub/ExternalDocument/2010/20100324_unaidsrghrtsissuepapertbhrts_en.pdf
Walsh GP, Tan EV, Dela Cruz EC, Abalos RM, Villahermosa LG, Young LJ, Cellona RV, Nazareno JB, Horwitz MA (1996) The Philippine cynomolgus monkey (Macaca fasicularis) provides a new nonhuman primate model of tuberculosis that resembles human disease. Nat Med 2:430–436
WHO (2009). Report: global tuberculosis control—epidemiology, strategy, financing. http://www.who.int/tb/publications/global_report/2009/index.html
Acknowledgments
The authors thank Dr. Sugawara I (the Research Institute of Tuberculosis, Tokyo) for providing the M. tuberculosis H37Rv strain. We are grateful to Junhui Wu for his kind review of the manuscript. This study was supported by the grants (2009ZX10004-402) from the Mega-Projects of Science Research for the 11th Five-Year Plan, China, 2009ZX10004-402.
Conflicts of interest
There are no any ethical or financial conflicts of interest for all authors. The corresponding authors, Drs. Wenzhe Ho and Zhi-Jiao Tang, take responsibility on behalf of all authors for the authorship, authenticity, and integrity of this manuscript.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Jing Zhang and Yan-Qing Ye contributed equally to this study.
Part of this work was presented in the 15th SNIP Scientific Conference, Wuhan City, Hubei, P.R. China, April 21–24, 2009.
Rights and permissions
About this article
Cite this article
Zhang, J., Ye, YQ., Wang, Y. et al. M. tuberculosis H37Rv Infection of Chinese Rhesus Macaques. J Neuroimmune Pharmacol 6, 362–370 (2011). https://doi.org/10.1007/s11481-010-9245-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11481-010-9245-4